31 – 40 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia.
(
- Contribution to journal › Article
-
Mark
A Swedish family with de novo alpha-synuclein A53T mutation: Evidence for early cortical dysfunction.
(
- Contribution to journal › Article
-
Mark
Rodent models of treatment-induced motor complications in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The Parkinson’s Disease Activities of Daily Living Scale (PADLS) revisited.
2009) World Congress on Parkinson’s Disease and Related Disorders In Parkinsonism and Related Disorders 15(S2). p.62-62(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Functional balance performance in patients with Parkinson's disease after long-term treatment with subthalamic nucleus high-frequency stimulation
(
- Contribution to journal › Article
- 2007
-
Mark
Fulfilment of patients' goals after thalamic deep brain stimulation: A follow-up study.
(
- Contribution to journal › Article
-
Mark
L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
(
- Contribution to journal › Article
-
Mark
The "Lister family": An extended pedigree with alpha-synuclein multiplications and Parkinson's disease.
2007) XVII WFN World Congress on Parkinson's Disease and Related Disorders, 2007 In Parkinsonism & Related Disorders 13(supplement 2). p.95-96(
- Contribution to journal › Published meeting abstract
- 2006
-
Mark
Estimating the value of novel interventions for Parkinson's disease: An early decision-making model with application to dopamine cell replacement.
(
- Contribution to journal › Article